Optivus Proton Therapy, Inc. Teams with Parsons Commercial Technology Group
Inc. to Produce Proton Beam Treatment Centers Globally
LOS ANGELES, Oct. 29 /PRNewswire/ -- Yesterday, at the 49th Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), Optivus Proton Therapy, Inc. (Optivus(R)) and Parsons Commercial Technology Group Inc., a global business unit of Parsons Corporation, announced a historic teaming agreement has been formalized between the two companies to globally produce turn-key proton beam therapy centers.
"The agreement between the teams of Optivus and Parsons will assure our clients that their proton system will be completed on time by the most expert team in the field," said Jon Slater, Optivus President and CEO. "This is a win/win/win situation for Optivus, Parsons and our clients."
Founded in 1944, Parsons is one of the largest 100% employee-owned management, engineering, and construction companies in the United States.
"Parsons collaborates with innovators and leaders in many diversified markets. We are thrilled to add the development of proton beam therapy centers, with Optivus, to our wide-ranging portfolio," said John Small, Parsons Group President.
Optivus was formed by the engineers who designed and installed the world's first and most successful hospital-based proton center at Loma Linda University Medical Center in Loma Linda, California. The facility commissioned and maintained by Optivus has enjoyed more success than all other comparable competitors' systems, with higher throughput, the most patients treated, and the most types of diseases treated with the most reliable and efficient device on the market.
"Interest in the development of proton treatment centers has grown at
an enormous rate in recent years and can largely be attributed to our
successes," Slater said. "This development will further reinforce our
position as the global leader in proton therapy t
|SOURCE Optivus Proton Therapy, Inc.|
Copyright©2007 PR Newswire.
All rights reserved